Spanish Red Biotech Pipeline
< Back
Drugs: Multinational Subsidiaries
Home
Toggle navigation
Pipeline
DRUGS: MULTINATIONAL SUBSIDIARIES
DRUGS: NATIONAL COMPANIES
RESEARCH PLATFORMS
DIAGNOSTICS AND PERSONALIZED MEDICINE
OTHER TECHNOLOGIES
Search
Charts
DRUGS: MULTINATIONAL SUBSIDIARIES
DRUGS: NATIONAL COMPANIES
DIAGNOSTICS AND PERSONALIZED MEDICINE
OTHER TECHNOLOGIES
Green pipeline
White pipeline
Spanish Red Biotech Pipeline
/
Pipeline
/
Drugs: Multinational Subsidiaries
TiGenix
Cx611
Type:
Gene / Cell Therapy
Therapeutic area:
Autoimmune & Inflammation
Infections
Indication:
Severe sepsis
Phase:
2
Phase II in Spain
,
1
Phase I in Spain